Can serum catecholamine at 1 week after I-131 MIBG therapy predict response in malignant pheochromocytoma?

被引：0
|
作者：
Higuchi, T. [1 ]
Oriuchi, N. [1 ]
Arisaka, Y. [1 ]
Miyashita, G. [2 ]
Ishikia, T. [2 ]
Hanaoka, H. [3 ]
Otake, H. [4 ]
Koyama, K. [5 ]
Endo, K. [1 ]
机构：
[1] Gunma Univ, Grad Sch Med, Dept Diagnost Radiol & Nucl Med, Maebashi, Gunma 371, Japan
[2] Gunma Univ, Grad Sch Med, Dept Stomatol & Maxillofacial Surg, Maebashi, Gunma 371, Japan
[3] Gunma Univ, Grad Sch Med, Dept Bioimaging Informat Anal, Maebashi, Gunma 371, Japan
[4] Gunma Univ Hosp, Dept Radiol, Maebashi, Gunma, Japan
[5] Gunma Prefectural Cardiovasc Ctr, Dept Radiol, Maebashi, Gunma, Japan
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2009年 / 36卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：S418 / S418
页数：1
相关论文
共 50 条
  • [41] Proteinuria in Metastatic Pheochromocytoma is Associated with an Increased Risk of Acute Respiratory Distress Syndrome, Spontaneously or After Therapy with 131I-Meta-iodobenzylguanidine (131I-MIBG)
    Porzig, A.
    Matthay, K. K.
    Dubois, S.
    Pampaloni, M.
    Damon, L.
    Hawkins, R.
    Goldsby, R.
    Hollinger, F.
    Fitzgerald, P.
    HORMONE AND METABOLIC RESEARCH, 2012, 44 (07) : 539 - 542
  • [42] Subsequent therapy can be administered after tositumomab and iodine I-131 tositumomab for non-Hodgkin lymphoma
    Dosik, AD
    Coleman, M
    Kostakoglu, L
    Furman, RR
    Fiore, JM
    Muss, D
    Niesvizky, R
    Shore, T
    Schuster, MW
    Stewart, P
    Vallabhajosula, S
    Goldsmith, SJ
    Leonard, JP
    CANCER, 2006, 106 (03) : 616 - 622
  • [43] Predictive Value of Serum Thyroglobuline Levels after I-131 Radiation Ablative Therapy in Differentiated Thyroid Carcinoma
    Joe, A. Y.
    Biermann, K.
    Bucerius, J.
    Brockmann, H.
    Biersack, H.
    Reinhardt, M. J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2005, 32 : S112 - S112
  • [44] Short-term repeated I-131 metaiodobenzylguanidine (MIBG) therapy prevents disease progression and reduces tumor metabolic activities in patients with malignant neuroendocrine tumors
    Yoshinaga, Keiichiro
    Okamoto, Shozo
    Shiga, Tohru
    Shinohara, Nobuo
    Abe, Takashige
    Tamaki, Nagara
    JOURNAL OF NUCLEAR MEDICINE, 2014, 55
  • [45] Ectopic thyroid tissue in thyroglossal duct remnant is related to elevation of serum thyroglobulin after I-131 ablation therapy
    Jeong, Geum-Cheol
    Park, Ki Seong
    Park, Hee Jeong
    Cho, Sang-Geon
    Kang, Sae-Ryung
    Kim, Jahae
    Kwon, Seong Young
    Min, Jung-Joon
    Song, Ho-Chun
    Bom, Hee-Seung
    JOURNAL OF NUCLEAR MEDICINE, 2014, 55
  • [46] Ectopic thyroid tissue in thyroglossal duct remnant is related to elevation of serum thyroglobulin after I-131 ablation therapy
    Jeong, Geum-Cheol
    Park, Ki Seong
    Park, Hee Jeong
    Cho, Sang-Geon
    Kang, Sae-Ryung
    Kim, Jahae
    Kwon, Seong Young
    Min, Jung-Joon
    Song, Ho-Chun
    Bom, Hee-Seung
    JOURNAL OF NUCLEAR MEDICINE, 2014, 55
  • [47] Measurement of serum thyroglobulin levels in patients with toxic adenoma and multinodular tosic goiter before and after the therapy with I-131
    Bonefacic, B.
    Grbac-Ivankovic, S.
    Petretic-Majnaric, S.
    Smokvina, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S444 - S444
  • [48] Metastatic Extra-Adrenal Pheochromocytoma with Single Kidney and Renal Compromise: A Case Report of Excellent Response, Tolerability, and Outcome to a Modified Regimen of 131 I-mIBG, and Decision-Making between 131 I-mIBG Therapy and PRRT
    Loharkar, Sarvesh
    Basu, Sandip
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2022, 43 (02) : 208 - 215
  • [49] Improved Survival in Stage IV NETs Treated With High Dose I-131 MIBG is Predicted by Response at Initial Follow-up and by Multiple Rounds of Therapy
    Morse, Michael
    Kane, Ari
    Thorpe, Matthew
    Oldan, Jorge
    Zhu, Jason
    Borges-Neto, Salvador
    PANCREAS, 2017, 46 (03) : 440 - 440
  • [50] Impact of Whole-Body Radiation Dose on Response and Toxicity in Patients With Neuroblastoma After Therapy With 131I-Metaiodobenzylguanidine (MIBG)
    Trieu, Megan
    DuBois, Steven G.
    Pon, Elizabeth
    Nardo, Lorenzo
    Hawkins, Randall A.
    Marachelian, Araz
    Twist, Clare J.
    Park, Julie R.
    Matthay, Katherine K.
    PEDIATRIC BLOOD & CANCER, 2016, 63 (03) : 436 - 442
12345